Related Articles
MYCN‑amplified neuroblastoma cell‑derived exosomal miR‑17‑5p promotes proliferation and migration of non‑MYCN amplified cells Corrigendum in /10.3892/mmr.2024.13349
MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68
Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line
lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration